Shares of Hims & Hers Health jumped after the company added former Food and Drug Administration official Deb Autor to its board. The stock was up 8.8% at $21.02 in Monday trading. Shares have doubled ...

Those ever-present TV drug ads showing patients hiking, biking or enjoying a day at the beach could soon have a different ...

Hims & Hers Health, announced Deb Autor, former deputy commissioner at the FDA, will join the company’s board of directors, and Janet ...

Hims & Hers offers personalized telehealth services, with a stock price that reflects high-growth potential. See why we ...

The best online providers offer strong support services to help you succeed in your GLP-1 weight loss journey.

Amazon acquired primary care provider One Medical for $3.9 billion in 2022, and fills prescriptions through Amazon One ...

The FDA spent more than 15 years crafting the guidelines, which are designed to do away with industry practices that downplay ...

Waystar upped its 2024 outlook and now expects total revenue to range between $926 million and $934 million, compared to ...

The expanded services help customers receive consultations and medications for erectile dysfunction, men’s hair loss, eyelash growth, motion sickness, and anti-aging skin care.

Hims & Hers’s stock fell 24% Thursday ... Amazon's online pharmacy partnered with Lilly in March to fill prescriptions for ...

Hims & Hers Health, a telehealth service for clients to access healthcare and prescriptions from home, is seeing its stock ...

Hims & Hers Health Inc. shares tumbled 22% Thursday, on concerns that Amazon.com Inc.'s latest push into healthcare will disrupt Hims & Hers' business.